Skip to content
Open access

Trends, cross-country inequalities and risk factors in the global burden of chronic obstructive pulmonary disease mortality, 1990–2021: a secondary data analysis of the Global Burden of Disease Study 2021

Oct 2026 · Tobacco Induced Diseases · Vol 24, pp. 1-14 · 0 citations · 28 references
Medicine

TL;DR

Differentiated prevention and control strategies targeting low SDI regions, with attention to gender and older population differences, are needed to address key risk factors and reduce health inequalities.

Abstract

INTRODUCTION Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Understanding the mortality trends and influencing factors of chronic obstructive pulmonary disease is crucial for addressing systemic health disparities and informing fair decision-making.

Methods

This is a secondary data analysis based on the Global Burden of Disease Study 2021. The mortality burden of COPD from 1990 to 2021 was evaluated using decomposition analysis, risk factor analysis, health inequality analysis, and the autoregressive integrated moving average (ARIMA) prediction model.

Results

Globally, COPD deaths increased from 2495513.45 (95% UI: 2238986.25–2694755.05) in 1990 to 3719936.55 (95% UI: 3347912.32–4084218.2) in 2021, while the age-standardized mortality rate per 100000 population (ASMR) decreased from 71.92 (95% UI: 64.47–77.53) to 45.22 (95% UI: 40.61–49.7). Significant reductions in ASMR were observed in high and high-middle sociodemographic index (SDI) regions, whereas low and low-middle SDI regions saw minimal improvements. The highest ASMRs were noted in Oceania, South Asia, and East Asia. Risk factors such as environmental/occupational risks, air pollution, and tobacco use remained significant contributors to COPD mortality. Gender disparities were evident, with males having higher ASMRs than females, particularly after the age of 60 years. Cross-country health inequalities worsened, with the concentration index indicating a shift towards greater burden in low SDI countries. The future forecast indicated that ASMR will continue to decrease to 19.97 (95% CI: 10.98–28.96) by 2051.

Conclusions

Despite overall improvements in COPD mortality rates, the increasing total number of deaths underscores the challenges posed by demographic shifts and health inequalities. Differentiated prevention and control strategies targeting low SDI regions, with attention to gender and older population differences, are needed to address key risk factors and reduce health inequalities.

Read PDF

Similar papers

Open access Sep 2026

Global, regional, and 204 countries burden of disease attributed to secondhand smoke-related COPD, 1990–2021: A secondary data analysis of the Global Burden of Disease Study 2021

INTRODUCTION Chronic obstructive pulmonary disease (COPD) imposes a significant economic burden on global public health systems. This secondary data analysis aims to estimate the disease burden of COPD attributable to secondhand smoke exposure from 1990 to 2021. METHODS Data on mortality, age-standardized mortality rat...

Qian-Shuo Huang, Le-Wen Fu, Sajid Ali et al. · 0 citations
Open access Oct 2026

Global, Regional, and National Burden of Chronic Obstructive Pulmonary Disease–Associated Heart Failure: A Systematic Analysis of the Global Burden of Disease Study from 1990 to 2021 with Projections up to 2050

Background Chronic obstructive pulmonary disease (COPD) is strongly linked to heart failure (HF), but comprehensive global evaluations of COPD-associated HF remain limited. Methods Using Global Burden of Disease Study 2021 data, we assessed prevalence and years lived with disability (YLDs) of COPD-associated HF. We app...

Can-Shi Liu, Hai-Tian Zhang, Zheng-Yan Wang et al. · 0 citations
Oct 2026

Global, regional, and national burden and trends in chronic kidney disease attributable to metabolic risk, 1990-2021: based on global burden of disease data, 2021.

BACKGROUND Global chronic kidney disease (CKD) burden from metabolic risks has risen steadily. Using 2021 Global Burden of Disease (GBD) data, this study examines 1990-2021 spatiotemporal trends and regional disparities in CKD to inform prevention. METHODS We analyzed 1990-2021 GBD data on metabolic-related CKD burde...

Ke-Rong Jiang, Li-Min Yin, Yong-Sheng Pan et al. · 1 citation
Open access Oct 2026

Global Burden, Temporal Trends, Extrapolation Based on Past Trends, and Population Attributable Fractions of Risk Factors for Type 2 Diabetes Mellitus: An Ecological Study Based on the Global Burden of Disease Study 2021

ABSTRACT Background and Aims Amidst the rising global impact of type 2 diabetes mellitus (T2DM), long‐term extrapolations and attributable risk estimations are essential for strategic healthcare planning. This study aimed to investigate the T2DM burden among adults aged ≥ 25 years, extrapolate trends to 2040, and quant...

A. Mirahmadizadeh, J. Hassanzadeh, M. Sayadi et al. · 0 citations
Open access Oct 2026

Trends in the Asthma Burden Attributable to High Body Mass Index in Children Across 204 Countries and Territories, 1990–2021: An Analysis of the 2021 Global Burden of Disease Study

ABSTRACT High body mass index (BMI) has been identified as a significant risk factor for childhood asthma. Given the rising prevalence of childhood obesity, assessing the impact of high BMI on asthma burden trends is imperative. Utilizing Global Burden of Disease (GBD) data, we estimated age‐, sex‐, geography‐, and soc...

Hua Li, Hai-Yang Chen, Dong-Zhi Zheng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.